Autolus Therapeutics Stock (NASDAQ: AUTL) stock price, news, charts, stock research, profile.
You can purchase shares of Autolus Therapeutics (NASDAQ:AUTL) through any online brokerage.
Other companies in Autolus Therapeutics’s space includes: Tectonic Therapeutic (NASDAQ:TECX), Immunome (NASDAQ:IMNM), 89bio (NASDAQ:ETNB), Humacyte (NASDAQ:HUMA) and Upstream Bio (NASDAQ:UPB).
Autolus Therapeutics has a consensus price target of $9.14.
The stock price for Autolus Therapeutics (NASDAQ: AUTL) is $2.3298 last updated January 17, 2025 at 4:50 PM EST.
There are no upcoming dividends for Autolus Therapeutics.
Autolus Therapeutics’s Q4 earnings are confirmed for Thursday, March 13, 2025.
There is no upcoming split for Autolus Therapeutics.
Autolus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.